Paul Rubin
38Patents
10h-index
21Co-inventors
75Inventor score
Filing activity: Feb 11, 1997 → Aug 5, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6458374B1 | Methods and compositions for treating chronic disorders using optically pure (+)-bupropion | Human Necessities | 112 | Expired |
| US6384038B1 | Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants | Human Necessities | 33 | Expired |
| US6369079B1 | Methods for treating irritable bowel syndrome using optically pure (+) norcisapride | Human Necessities | 32 | Expired |
| US5900421A | Methods and compositions for treating allergic asthma and dermatitis using descarboethoxyloratadine | Human Necessities | 23 | Expired |
| US6649183B2 | Methods for treating apnea and apnea disorders using optically pure R(+) ondansetron | Human Necessities | 21 | Expired |
| US6835740B2 | Methods for treating sleep apnea and sleep induced apnea using optically pure (+) norcisapride | Human Necessities | 17 | Expired |
| US6790849B2 | Methods and compositions using optically pure (-) cetirizine in combination with leukotriene inhibitors or decongestants | Human Necessities | 14 | Expired |
| US6548518B2 | Methods of treating gastro-esophogeal reflux disease using (-) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists | Human Necessities | 12 | Expired |
| US6552045B2 | Methods and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists | Human Necessities | 12 | Expired |
| US6559165B1 | Methods for treating bulimia using optically pure (−) norcisapride | Human Necessities | 11 | Expired |
| US6339086B1 | Methods of making and using N-desmethylzopiclone | Chemistry; Metallurgy | 7 | Expired |
| US6048879A | Methods for treating apnea, apnea disorders, bulimia, and other disorders using optically pure (+) norcisapride | Human Necessities | 7 | Expired |
| US6054463A | Methods for treating dermatitis using descarboethoxyloratadine | Human Necessities | 6 | Expired |
| US6548082B1 | Methods for treating apnea and apnea disorders using optically pure R(+) ondansetron | Human Necessities | 5 | Expired |
| US5962464A | Methods and compositions for treating allergic asthma using descarboethoxyloratadine | Human Necessities | 5 | Expired |
| US6194431A | Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors | Human Necessities | 4 | Expired |
| US6495605B2 | Methods and compositions for aiding in smoking cessation and for treating pain and other disorders using optically pure (+)-bupropion | Human Necessities | 4 | Expired |
| US6248308A | Methods of using norastemizole in combination with leukotriene inhibitors to treat or prevent asthma | Human Necessities | 3 | Expired |
| US6353005B1 | Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist | Human Necessities | 3 | Expired |
| US6620851B2 | Methods for the treatment of neuropathic pain and other disorders using R(−)-ketoprofen | Chemistry; Metallurgy | 3 | Expired |
| US6506753B2 | Methods of making and using N-desmethylzopiclone | Chemistry; Metallurgy | 2 | Expired |
| US6372197B1 | Methods and compositions using norastemizole in combination with leukotriene inhibitors | Human Necessities | 2 | Expired |
| US6458791B1 | Methods of treating muscle spasms using N-desmethylzopiclone | Chemistry; Metallurgy | 2 | Expired |
| US6946464B2 | Methods of treating and preventing a convulsive state | Chemistry; Metallurgy | 2 | Expired |
| US6509353B1 | Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors | Human Necessities | 1 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.